Riskpilot← Back to searchSign inGet full accessNelin Läkar AB
ABActiveOrg 5566729652Hagbyvägen 32General medical practice activities · NACE 8621Est. 20042 employees
Revenue 2025
SEK 2,7M
+31% vs 2024
EBITDA margin
45.4%
+57% vs 2024
Equity ratio
74.8%
Financial strength
Net profit 2025
SEK 914K
+66% vs 2024
| Revenue | SEK 2,7M | +31% |
| EBITDA | SEK 1,2M | +57% |
| Net profit | SEK 914K | +66% |
| Total assets | SEK 1,6M | +67% |
| Equity | SEK 1,2M | +83% |
| Employees | 2 | — |
Legal name
Nelin Läkar AB
Org number
5566729652
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 december 2004
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva medicinsk konsultation, äga och förvalta fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Hagbyvägen 32
Email
jan.nelin@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 367 | 1 192 | 1 301 | 2 033 | 2 670 |
| Staff expenses | — | −182 | −101 | −684 | −393 |
| EBITDA | 31 | 513 | 512 | 774 | 1 211 |
| Depreciation & amort. | −13 | −11 | −24 | −73 | −40 |
| EBIT | 18 | 502 | 488 | 700 | 1 171 |
| Net financials | −5 | −3 | −2 | −7 | −16 |
| Profit before tax | 13 | 499 | 487 | 694 | 1 155 |
| Tax | −3 | −102 | −102 | −144 | −241 |
| Net profit | 10 | 397 | 385 | 550 | 914 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 186 | 757 | 809 | 953 | 1 590 |
| Equity | 117 | 514 | 486 | 650 | 1 189 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 69 | 243 | 323 | 302 | 400 |
| Total debt | 69 | 243 | 323 | 302 | 400 |
EBITDA margin
45.4%
This company
15.8%
Market median
+187% vs market
20212025
Equity ratio
74.8%
This company
38.2%
Market median
+96% vs market
20212025
Return on equity
76.8%
This company
18.4%
Market median
+317% vs market
20212025
Net profit margin
34.2%
This company
8.1%
Market median
+322% vs market
20212025
Asset turnover
1.68×
This company
1.12×
Market median
+50% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nelin Läkar AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jessica Maria Nelin | Deputy Board Member | 0 companies |
| Jan Erik Nelin | Board of Directors | 0 companies |